tretinoin and Aspergillosis

tretinoin has been researched along with Aspergillosis* in 2 studies

Other Studies

2 other study(ies) available for tretinoin and Aspergillosis

Article	Year
Images in clinical medicine. Cerebral air embolism. The New England journal of medicine, 2012, Aug-30, Volume: 367, Issue:9 Topics: Adult; Aspergillosis; Cardiopulmonary Resuscitation; Embolism, Air; Fatal Outcome; Heart Arrest; Humans; Intracranial Embolism; Leukemia, Promyelocytic, Acute; Male; Radiography; Tretinoin	2012
Retinoic acid as antileukemic therapy in a patient with acute promyelocytic leukemia and Aspergillus pneumonia. Blood, 1986, Volume: 67, Issue:2 A patient with acute promyelocytic leukemia (APL) and laboratory evidence of fibrinolysis who could not be treated with aggressive cytostatic regimens because of Aspergillus pneumonia was treated with cis-retinoic acid (RA), a substance that can induce differentiation and maturation of APL cells. After seven weeks of daily oral treatment, he went into complete remission, and signs of coagulopathy disappeared. Meanwhile, the Aspergillus pneumonia could be treated adequately. Based on the experience in this single patient, RA deserves further evaluation in the treatment of APL. Topics: Adult; Aspergillosis; Bone Marrow; Humans; Leukemia, Myeloid, Acute; Male; Pneumonia; Tretinoin	1986

Article

Year

Images in clinical medicine. Cerebral air embolism.

The New England journal of medicine, 2012, Aug-30, Volume: 367, Issue:9

Topics: Adult; Aspergillosis; Cardiopulmonary Resuscitation; Embolism, Air; Fatal Outcome; Heart Arrest; Humans; Intracranial Embolism; Leukemia, Promyelocytic, Acute; Male; Radiography; Tretinoin

2012

Retinoic acid as antileukemic therapy in a patient with acute promyelocytic leukemia and Aspergillus pneumonia.

Blood, 1986, Volume: 67, Issue:2

A patient with acute promyelocytic leukemia (APL) and laboratory evidence of fibrinolysis who could not be treated with aggressive cytostatic regimens because of Aspergillus pneumonia was treated with cis-retinoic acid (RA), a substance that can induce differentiation and maturation of APL cells. After seven weeks of daily oral treatment, he went into complete remission, and signs of coagulopathy disappeared. Meanwhile, the Aspergillus pneumonia could be treated adequately. Based on the experience in this single patient, RA deserves further evaluation in the treatment of APL.

Topics: Adult; Aspergillosis; Bone Marrow; Humans; Leukemia, Myeloid, Acute; Male; Pneumonia; Tretinoin

1986